ALLO Allogene Therapeutics, Inc. - Common Stock
ALLO Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
ALLO Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Financial Health Debt, liquidity, solvency — balance sheet strength
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
ALLO Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
- Strong Buy 6 33.3%
- Buy 10 55.6%
- Hold 2 11.1%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
9 analysts · 2026-08-15Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| June 30, 2026 | $-0.13 | $-0.17 | 0.04% |
| March 31, 2026 | $-0.18 | $-0.19 | 0.01% |
| Dec. 31, 2025 | $-0.17 | $-0.22 | 0.05% |
| Sept. 30, 2025 | $-0.19 | $-0.23 | 0.04% |
| June 30, 2025 | $-0.23 | $-0.28 | 0.05% |
| March 31, 2025 | $-0.28 | $-0.30 | 0.02% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| ALLO | $314M | -1.6 | -76.8% | — | -59.9% | — |
| NGNE | $319M | -4.9 | — | — | -33.6% | — |
| STTK | $231M | -5.2 | -82.5% | -4880.9% | -70.0% | — |
| GYRE | $645M | 353.0 | 10.2% | 8.5% | 11.7% | — |
| NVCT | $194M | -5.7 | — | — | -149.9% | — |
| IRWD | $550M | 22.5 | -15.7% | 8.1% | -8.5% | — |
| TECX | $391M | -5.2 | — | — | -27.7% | — |
| EIKN | — | — | — | — | — | — |
| ASMB | $539M | -61.8 | 153.5% | -8.5% | -5.5% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 15
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $22.0K | $95.0K | $156.0K | $114M | $0 | $0 | |
| R&D Expense | $150M | $192M | $243M | $256M | $220M | $193M | $145M | |
| SG&A Expense | $57M | $65M | $72M | $79M | $74M | $65M | $57M | |
| Operating Expenses | $209M | $273M | $328M | $336M | $294M | $258M | $202M | |
| Operating Income | $-209M | $-273M | $-328M | $-336M | $-180M | $-258M | $-202M | |
| Interest Expense | · | · | · | · | · | $0 | $0 | |
| Other Non-op | $215.0K | $-4M | $-18M | $-9M | $-4M | $-67M | $17M | |
| Pretax Income | $-191M | $-257M | $-327M | · | $-257M | $-250M | $-185M | |
| Income Tax | $0 | $443.0K | $0 | $0 | $0 | $0 | $-331.0K | |
| Net Income | $-191M | $-258M | $-327M | $-340M | $-182M | $-316M | $-185M | |
| EPS (Basic) | $-0.87 | $-1.32 | $-2.09 | $-2.38 | $-1.34 | $-2.63 | $-1.83 | |
| EPS (Diluted) | $-0.87 | $-1.32 | $-2.09 | $-2.38 | $-1.34 | $-2.63 | $-1.83 | |
| Shares (Basic) | 220,622,669 | 194,811,756 | 156,931,778 | 143,147,165 | 135,820,386 | 120,370,177 | 101,061,149 | |
| Shares (Diluted) | 220,622,669 | 194,811,756 | 156,931,778 | 143,147,165 | 135,820,386 | 120,370,177 | 101,061,149 | |
| EBITDA | $-197M | $-260M | $-314M | · | $-245M | $-251M | $-197M |
Balance Sheet 21
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $52M | $75M | $83M | $62M | $173M | $183M | $175M | |
| Short-term Investments | · | · | · | · | $284M | $645M | $355M | |
| Prepaid Expense | $8M | $11M | $10M | $12M | $14M | $17M | $14M | |
| Current Assets | $258M | $303M | $459M | $529M | $471M | $845M | $545M | |
| PP&E (Net) | $73M | $86M | $99M | $113M | $123M | $119M | $56M | |
| PP&E (Gross) | $145M | $149M | $151M | $150M | $146M | $132M | $62M | |
| Accum. Depreciation | $73M | $63M | $51M | $37M | $23M | $13M | $5M | |
| Intangibles | · | · | · | · | · | $0 | $151.0K | |
| Other Non-current Assets | $4M | $2M | $7M | $10M | $6M | $5M | $5M | |
| Total Assets | $416M | $549M | $643M | $822M | $1.05B | $1.23B | $718M | |
| Accounts Payable | $4M | $5M | $6M | $14M | $10M | $10M | $9M | |
| Current Liabilities | $33M | $36M | $37M | $54M | $48M | $94M | $33M | |
| Capital Leases | $75M | $83M | $88M | $95M | $70M | $51M | $51M | |
| Other Non-current Liabilities | $16M | $8M | $5M | $6M | $8M | $3M | $4M | |
| Total Liabilities | $123M | $127M | $131M | $155M | $126M | $148M | $89M | |
| Common Stock | $229.0K | $212.0K | $169.0K | $144.0K | $142.0K | $140.0K | $124.0K | |
| Retained Earnings | $-2.01B | $-1.82B | $-1.56B | $-1.23B | $-895M | $-713M | $-396M | |
| AOCI | $269.0K | $-89.0K | $-955.0K | $-10M | $-3M | $268.0K | $1M | |
| Stockholders' Equity | $293M | $422M | $512M | $667M | $925M | $1.01B | $629M | |
| Liabilities + Equity | $416M | $549M | $643M | $822M | $1.05B | $1.23B | $718M | |
| Shares Outstanding | 229,413,523 | 212,210,597 | 168,642,238 | 144,438,304 | 142,623,065 | 140,474,305 | 124,267,358 |
Cash Flow 15
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $12M | $14M | $14M | $14M | $10M | $7M | $5M | |
| Stock-based Comp | $38M | $52M | $66M | $84M | $81M | $65M | $46M | |
| Deferred Tax | $0 | $443.0K | $0 | · | · | · | · | |
| Amort. of Intangibles | · | · | · | $0 | $0 | $151.0K | $603.0K | |
| Restructuring | $5M | · | · | · | · | · | · | |
| Other Non-cash | $-8M | $-9M | $9M | · | $-19M | $62M | $-3M | |
| Operating Cash Flow | $-149M | $-200M | $-238M | $-221M | $-185M | $-115M | $-137M | |
| CapEx | $386.0K | $694.0K | $2M | $5M | $21M | $66M | $51M | |
| Investing Cash Flow | $96M | $76M | $163M | $106M | $164M | $-505M | $164M | |
| Stock Issued | · | · | $91M | $0 | $0 | $596M | $0 | |
| Net Stock Activity | · | · | $91M | · | $0 | $622M | $54M | |
| Financing Cash Flow | $30M | $117M | $96M | $3M | $12M | $634M | $59M | |
| Net Change in Cash | $-24M | $-8M | $21M | $-111M | $-9M | $13M | $86M | |
| Free Cash Flow | $-150M | $-201M | $-239M | · | $-206M | $-181M | $-188M | |
| Levered FCF | · | · | · | · | · | $-181M | $-188M |
Profitability 7
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -1241813.6% | -344986.3% | · | -664.6% | · | · | |
| Net Margin | · | -1170863.6% | -344489.5% | · | -667.7% | · | · | |
| Pretax Margin | · | -1168850.0% | · | · | -667.7% | · | · | |
| EBITDA Margin | · | -1179818.2% | -330039.0% | · | -637.3% | · | · | |
| ROA | -39.6% | -43.2% | -48.3% | · | -22.7% | -25.7% | -24.8% | |
| ROE | -59.9% | -58.1% | -59.9% | · | -27.3% | -22.8% | -29.6% | |
| ROIC | -71.5% | -64.8% | · | · | -27.9% | -23.9% | -32.1% |
Liquidity & Solvency 2
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.9 | 8.5 | 12.4 | · | 9.8 | 9.0 | 16.5 | |
| Quick Ratio | 1.6 | 2.1 | 2.2 | · | 9.5 | 8.8 | 16.0 |
Efficiency 1
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | · | 0.0 | · | · |
Growth Rates 2
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | -76.8% | -39.1% | -99.9% | · | · | · | |
| Revenue CAGR 3Y | · | -94.2% | · | · | · | · | · |
Valuation (TTM) 10
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $22.0K | $95.0K | $156.0K | $114M | $0 | $0 | |
| Net Income TTM | $-191M | $-258M | $-327M | $-340M | $-182M | $-316M | $-185M | |
| Market Cap | $314M | $452M | $541M | · | $2.13B | $3.55B | $3.23B | |
| P/E | -1.6 | -1.6 | -1.5 | -2.6 | -11.1 | -9.6 | -14.2 | |
| P/S | · | 20545.8 | 5698.3 | · | 18.7 | · | · | |
| P/B | 1.1 | 1.1 | 1.1 | · | 2.3 | 3.3 | 5.1 | |
| P / Tangible Book | 1.1 | 1.1 | 1.1 | 1.4 | 2.3 | 3.5 | · | |
| P / Cash Flow | -2.1 | -2.3 | -2.3 | · | -11.5 | -30.8 | -23.5 | |
| P / FCF | -2.1 | -2.2 | -2.3 | · | -10.3 | -19.6 | -17.2 | |
| Earnings Yield | -63.5% | -62.0% | -65.1% | -37.8% | -9.0% | -10.4% | -7.0% |
Income Statement 12
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5M | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $22.0K | $21.0K | $22.0K | $22.0K | $30.0K | $-40.0K | $27.0K | |
| R&D Expense | $31M | $32M | $29M | $31M | $40M | $50M | $45M | $45M | $50M | $52M | $55M | $46M | $62M | $80M | $75M | $64M | |
| SG&A Expense | $21M | $14M | $14M | $14M | $14M | $15M | $16M | $16M | $16M | $17M | $17M | $17M | $19M | $19M | $21M | $19M | |
| Operating Expenses | $52M | $46M | $42M | $45M | $57M | $65M | $60M | $72M | $71M | $70M | $85M | $63M | $81M | $99M | $96M | $83M | |
| Operating Income | $-47M | $-46M | $-42M | $-45M | $-57M | $-65M | $-60M | $-72M | $-71M | $-70M | $-85M | $-63M | $-81M | $-99M | $-96M | $-83M | |
| Other Non-op | $-61.0K | $212.0K | $247.0K | $-81.0K | $-43.0K | $92.0K | $-2M | $-1M | $85.0K | $-929.0K | $-12M | $-5M | $-2M | $2M | $-10M | $-3M | |
| Net Income | $-43M | $-43M | $-39M | $-41M | $-51M | $-60M | $-60M | $-66M | $-66M | $-65M | $-86M | $-62M | $-79M | $-100M | $-103M | $-84M | |
| EPS (Basic) | $-0.13 | $-0.18 | $-0.17 | $-0.19 | $-0.23 | $-0.28 | $-0.27 | $-0.32 | $-0.35 | $-0.38 | $-0.49 | $-0.37 | $-0.54 | $-0.69 | $-0.72 | $-0.59 | |
| EPS (Diluted) | $-0.13 | $-0.18 | $-0.17 | $-0.19 | $-0.23 | $-0.28 | $-0.27 | $-0.32 | $-0.35 | $-0.38 | $-0.49 | $-0.37 | $-0.54 | $-0.69 | $-0.72 | $-0.59 | |
| Shares (Basic) | 328,930,269 | 240,290,782 | -435,704,178 | 222,038,680 | 218,929,548 | 215,358,619 | -373,531,795 | 209,188,551 | 190,026,638 | 169,128,362 | -302,076,887 | 167,649,010 | 146,795,826 | 144,563,829 | -285,255,907 | 143,661,721 | |
| Shares (Diluted) | 328,930,269 | 240,290,782 | -435,704,178 | 222,038,680 | 218,929,548 | 215,358,619 | -373,531,795 | 209,188,551 | 190,026,638 | 169,128,362 | -302,076,887 | 167,649,010 | 146,795,826 | 144,563,829 | -285,255,907 | 143,661,721 | |
| EBITDA | $-47M | $-43M | · | $-45M | $-57M | $-62M | · | $-72M | $-71M | $-70M | · | $-63M | $-81M | $-99M | · | $-82M |
Balance Sheet 19
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $39M | $30M | $52M | $38M | $52M | $42M | $75M | $51M | $171M | $51M | $83M | $69M | $155M | $110M | $62M | $74M | |
| Prepaid Expense | $7M | $6M | $8M | $9M | $10M | $12M | $11M | $13M | $12M | $11M | $10M | $8M | $10M | $10M | $12M | $17M | |
| Current Assets | $340M | $273M | $258M | $261M | $283M | $292M | $303M | $304M | $457M | $395M | $459M | $473M | $502M | $481M | $529M | $569M | |
| PP&E (Net) | $67M | $70M | $73M | $76M | $79M | $83M | $86M | $89M | $92M | $96M | $99M | $103M | $106M | $110M | $113M | $114M | |
| PP&E (Gross) | $145M | $145M | $145M | $145M | $146M | $149M | $149M | $149M | $148M | $151M | $151M | $150M | $150M | $150M | $150M | $149M | |
| Accum. Depreciation | $78M | $75M | $73M | $70M | $67M | $66M | $63M | $60M | $56M | $55M | $51M | $48M | $44M | $40M | $37M | $35M | |
| Other Non-current Assets | $4M | $4M | $4M | $4M | $4M | $2M | $2M | $5M | $6M | $5M | $7M | $10M | $9M | $9M | $10M | $9M | |
| Total Assets | $550M | $396M | $416M | $440M | $471M | $508M | $549M | $589M | $647M | $586M | $643M | $712M | $771M | $747M | $822M | $888M | |
| Accounts Payable | $6M | $5M | $4M | $4M | $5M | $5M | $5M | $6M | $13M | $6M | $6M | $6M | $10M | $15M | $14M | $11M | |
| Current Liabilities | $32M | $28M | $33M | $32M | $32M | $30M | $36M | $33M | $37M | $31M | $37M | $38M | $55M | $60M | $54M | $49M | |
| Capital Leases | $70M | $73M | $75M | $77M | $79M | $81M | $83M | $85M | $87M | $89M | $88M | $90M | $92M | $94M | $95M | $97M | |
| Other Non-current Liabilities | $12M | $16M | $16M | $15M | $15M | $11M | $8M | $8M | $8M | $5M | $5M | $1M | $2M | $2M | $6M | $2M | |
| Total Liabilities | $114M | $117M | $123M | $124M | $126M | $123M | $127M | $125M | $132M | $125M | $131M | $129M | $148M | $155M | $155M | $148M | |
| Common Stock | $345.0K | $245.0K | $229.0K | $223.0K | $220.0K | $219.0K | $212.0K | $210.0K | $209.0K | $170.0K | $169.0K | $168.0K | $167.0K | $146.0K | $144.0K | $144.0K | |
| Retained Earnings | $-2.10B | $-2.05B | $-2.01B | $-1.97B | $-1.93B | $-1.88B | $-1.82B | $-1.76B | $-1.69B | $-1.63B | $-1.56B | $-1.47B | $-1.41B | $-1.33B | $-1.23B | $-1.14B | |
| AOCI | $-518.0K | $-183.0K | $269.0K | $235.0K | $-45.0K | $43.0K | $-89.0K | $157.0K | $-780.0K | $-927.0K | $-955.0K | $-2M | $-4M | $-6M | $-10M | $-13M | |
| Stockholders' Equity | $436M | $279M | $293M | $315M | $345M | $385M | $422M | $464M | $515M | $461M | $512M | $583M | $623M | $592M | $667M | $740M | |
| Liabilities + Equity | $550M | $396M | $416M | $440M | $471M | $508M | $549M | $589M | $647M | $586M | $643M | $712M | $771M | $747M | $822M | $888M | |
| Shares Outstanding | 345,345,427 | 244,816,413 | 229,413,523 | 223,163,672 | 220,133,876 | 218,598,262 | 212,210,597 | 209,500,137 | 209,049,485 | 170,452,967 | 168,642,238 | 168,175,221 | 167,133,664 | 145,740,333 | 144,438,304 | 144,031,588 |
Cash Flow 12
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $3M | $4M | · | · | · | · | |
| Stock-based Comp | $12M | $8M | $8M | $9M | $9M | $12M | $13M | $13M | $14M | $12M | $15M | $15M | $17M | $19M | $17M | $21M | |
| Restructuring | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $19M | · | · | · | $-8M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-32M | $-13M | $-28M | $-30M | $-39M | $-53M | $-37M | $-44M | $-64M | $-56M | $-54M | $-56M | $-62M | $-67M | $-62M | $-48M | |
| CapEx | $150.0K | $9.0K | $0 | $243.0K | $44.0K | $99.0K | $257.0K | $429.0K | $0 | $8.0K | $181.0K | $12.0K | $288.0K | $1M | $2M | $223.0K | |
| Investing Cash Flow | $-148M | $-30M | $34M | $12M | $44M | $6M | $55M | $-76M | $75M | $22M | $67M | $-34M | $17M | $113M | $50M | $25M | |
| Stock Issued | · | · | · | · | · | $10M | · | · | · | $0 | · | $3M | · | · | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | $10M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $188M | $21M | $8M | $3M | $5M | $14M | $6M | $679.0K | $109M | $2M | $155.0K | $4M | $90M | $2M | $46.0K | $1M | |
| Net Change in Cash | $8M | $-21M | $14M | $-15M | $10M | $-33M | $24M | $-119M | $120M | $-32M | $14M | $-86M | $45M | $48M | $-12M | $-22M | |
| Free Cash Flow | · | $-13M | · | · | · | $-53M | · | · | · | $-56M | · | · | · | $-68M | · | · |
Profitability 5
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1011.2% | · | · | · | · | · | · | · | · | -315927.3% | · | -146453.5% | -182995.5% | -190519.2% | · | -168344.9% | |
| Net Margin | -919.8% | · | · | · | · | · | · | · | · | -295454.6% | · | -142593.0% | -177247.7% | -189815.4% | · | -169689.8% | |
| EBITDA Margin | -1011.2% | · | · | · | · | · | · | · | · | -315927.3% | · | -146453.5% | -182995.5% | -190519.2% | · | -168344.9% | |
| ROA | -8.4% | -9.4% | · | -8.1% | -9.1% | -10.9% | · | -10.2% | -9.4% | -9.8% | · | -7.7% | -9.1% | -11.5% | · | -8.5% | |
| ROE | -10.9% | -12.8% | · | -10.6% | -11.8% | -14.1% | · | -12.7% | -11.7% | -12.3% | · | -9.3% | -10.9% | -13.6% | · | -9.7% |
Liquidity & Solvency 2
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.7 | 9.6 | · | 8.2 | 8.9 | 9.7 | · | 9.3 | 12.3 | 12.8 | · | 12.6 | 9.2 | 8.1 | · | 11.6 | |
| Quick Ratio | 1.2 | 1.1 | · | 1.2 | 1.7 | 1.4 | · | 1.6 | 4.6 | 1.7 | · | 1.8 | 2.8 | 1.8 | · | 1.5 |
Efficiency 1
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
Valuation (TTM) 10
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $0 | · | $0 | $0 | $22.0K | · | $44.0K | $66.0K | $96.0K | · | $101.0K | $143.0K | $160.0K | · | $179.0K | |
| Net Income TTM | $-178M | $-195M | · | $-218M | $-243M | $-257M | · | $-260M | $-273M | $-306M | · | $-326M | $-344M | $-343M | · | $-321M | |
| Market Cap | $718M | $597M | · | $277M | $249M | $319M | · | $587M | $487M | $762M | · | $533M | $831M | $720M | · | $1.56B | |
| P/E | -2.8 | -2.8 | · | -1.2 | -1.0 | -1.1 | · | -2.0 | -1.4 | -2.3 | · | -1.4 | -2.1 | -2.1 | · | -4.7 | |
| P/S | · | · | · | · | · | 14507.0 | · | 13331.8 | 7380.1 | 7936.7 | · | 5278.4 | 5808.8 | 4499.7 | · | 8690.2 | |
| P/B | 1.6 | 2.1 | · | 0.9 | 0.7 | 0.8 | · | 1.3 | 0.9 | 1.7 | · | 0.9 | 1.3 | 1.2 | · | 2.1 | |
| P / Tangible Book | 1.6 | 2.1 | · | 0.9 | 0.7 | 0.8 | · | 1.3 | 0.9 | 1.7 | · | 0.9 | 1.3 | 1.2 | · | 2.1 | |
| P / Cash Flow | · | -46.3 | · | · | · | -6.0 | · | · | · | -13.6 | · | · | · | -10.8 | · | · | |
| P / FCF | · | -46.2 | · | · | · | -6.0 | · | · | · | -13.6 | · | · | · | -10.6 | · | · | |
| Earnings Yield | -35.1% | -36.1% | · | -82.3% | -104.4% | -91.1% | · | -50.7% | -70.4% | -44.3% | · | -69.1% | -47.9% | -48.6% | · | -21.1% |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | |
|---|---|---|---|---|---|
| Revenue | $0 | $22.0K | $95.0K | — | — |
| Operating Margin % | — | -1241813.6% | -344986.3% | — | — |
| Net Income | $-191M | $-258M | $-327M | — | — |
| Diluted EPS | $-0.87 | $-1.32 | $-2.09 | — | — |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | |
|---|---|---|---|---|---|
| Current Ratio | 7.9 | 8.5 | 12.4 | — | — |
| Quick Ratio | 1.6 | 2.1 | 2.2 | — | — |
Cash Flow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | |
|---|---|---|---|---|---|
| Free Cash Flow | $-150M | $-201M | $-239M | — | — |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 231 filers · $530.0M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 37 (-15 vs prior Q) | 25 (+14 vs prior Q) | 90 (+13 vs prior Q) | 55 (+12 vs prior Q) | +113.5M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Pfizer Inc | $46,928,245 | 22,032,040 | 8.85% | Shares |
| Frazier Life Sciences Management, L.P. | $46,689,069 | 22,446,668 | 8.81% | Shares |
| STATE STREET CORP | $39,573,718 | 19,025,826 | 7.47% | Shares |
| TPG GP A, LLC | $38,929,916 | 18,716,306 | 7.34% | Shares |
| Sio Capital Management, LLC | $27,712,736 | 13,323,431 | 5.23% | Shares |
| PRIMECAP MANAGEMENT CO/CA/ | $27,296,756 | 13,123,440 | 5.15% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $25,306,603 | 12,166,636 | 4.77% | Shares |
| FMR LLC | $24,957,776 | 11,998,931 | 4.71% | Shares |
| CITADEL ADVISORS LLC | $19,676,871 | 9,460,034 | 3.71% | Shares |
| TWO SIGMA INVESTMENTS, LP | $16,191,444 | 7,784,348 | 3.05% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $12,494,150 | 6,005,150 | 2.36% | Shares |
| GOLDMAN SACHS GROUP INC | $12,467,422 | 5,993,953 | 2.35% | Shares |
| VANGUARD GROUP INC | $11,178,392 | 8,159,410 | 2.11% | Shares |
| GordonMD Global Investments LP | $11,019,840 | 5,298,000 | 2.08% | Shares |
| Patient Square Capital LP | $10,504,000 | 5,050,000 | 1.98% | Shares |
| Aberdeen Group plc | $10,403,644 | 5,001,752 | 1.96% | Shares |
| MILLENNIUM MANAGEMENT LLC | $10,075,289 | 4,843,889 | 1.90% | Shares |
| Woodline Partners LP | $9,361,298 | 4,500,624 | 1.77% | Shares |
| Candriam S.C.A. | $9,010,818 | 4,336,296 | 1.70% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $8,761,122 | 4,212,078 | 1.65% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $7,975,369 | 3,834,312 | 1.50% | Shares |
| Walleye Capital LLC | $6,797,465 | 3,268,012 | 1.28% | Shares |
| RTW INVESTMENTS, LP | $6,760,000 | 3,250,000 | 1.28% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $6,397,849 | 3,075,889 | 1.21% | Shares |
| Ghisallo Capital Management LLC | $6,240,000 | 3,000,000 | 1.18% | Shares |
| Wildcat Capital Management, LLC | $6,075,237 | 2,920,787 | 1.15% | Shares |
| BANK OF AMERICA CORP /DE/ | $6,043,750 | 2,905,649 | 1.14% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $4,730,675 | 2,274,363 | 0.89% | Shares |
| DAFNA Capital Management LLC | $4,160,000 | 2,000,000 | 0.78% | Shares |
| TWO SIGMA ADVISERS, LP | $3,959,574 | 2,890,200 | 0.75% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $3,823,756 | 1,838,344 | 0.72% | Shares |
| Boxer Capital Management, LLC | $3,120,000 | 1,500,000 | 0.59% | Shares |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $3,026,614 | 1,455,103 | 0.57% | Shares |
| Raiffeisen Bank International AG | $2,442,000 | 1,100,000 | 0.46% | Shares |
| Vida Ventures Advisors, LLC | $2,229,722 | 1,798,163 | 0.42% | Shares |
| BlackRock, Inc. | $2,142,876 | 1,030,229 | 0.40% | Shares |
| Man Group plc | $1,459,954 | 701,901 | 0.28% | Shares |
| RAYMOND JAMES FINANCIAL INC | $1,412,262 | 678,972 | 0.27% | Shares |
| Mitsubishi UFJ Asset Management Co., Ltd. | $1,138,153 | 547,189 | 0.21% | Shares |
| CITIGROUP INC | $1,038,914 | 499,478 | 0.20% | Shares |
| Voleon Capital Management LP | $1,010,092 | 485,621 | 0.19% | Shares |
| AMERIPRISE FINANCIAL INC | $977,182 | 469,799 | 0.18% | Shares |
| TD Asset Management Inc | $961,126 | 462,080 | 0.18% | Shares |
| MACKENZIE FINANCIAL CORP | $893,489 | 429,562 | 0.17% | Shares |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $886,650 | 426,274 | 0.17% | Shares |
| Erste Asset Management GmbH | $846,708 | 381,400 | 0.16% | Shares |
| ALPS ADVISORS INC | $728,630 | 350,303 | 0.14% | Shares |
| Rafferty Asset Management, LLC | $702,073 | 337,535 | 0.13% | Shares |
| Connor, Clark & Lunn Investment Management Ltd. | $666,114 | 320,247 | 0.13% | Shares |
| RHUMBLINE ADVISERS | $644,248 | 309,741 | 0.12% | Shares |
| Moloney Securities Asset Management, LLC | $637,360 | 514,000 | 0.12% | Shares |
| Harold Davidson & Associates Inc. | $585,566 | 281,522 | 0.11% | Shares |
| IEQ CAPITAL, LLC | $582,257 | 279,931 | 0.11% | Shares |
| Bank of New York Mellon Corp | $558,216 | 268,373 | 0.11% | Shares |
| HSBC HOLDINGS PLC | $557,157 | 259,747 | 0.11% | Shares |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $554,147 | 266,417 | 0.10% | Shares |
| ALLIANCEBERNSTEIN L.P. | $551,142 | 225,878 | 0.10% | Shares |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $520,000 | 250,000 | 0.10% | Shares |
| Squarepoint Ops LLC | $502,370 | 241,524 | 0.09% | Shares |
| UBS Group AG | $494,220 | 237,606 | 0.09% | Shares |
| BIT Capital GmbH | $478,400 | 230,000 | 0.09% | Shares |
| WELLS FARGO & COMPANY/MN | $462,342 | 222,280 | 0.09% | Shares |
| LPL Financial LLC | $458,994 | 220,670 | 0.09% | Shares |
| Vanguard Global Advisers, LLC | $447,585 | 215,185 | 0.08% | Shares |
| CAXTON ASSOCIATES LP | $439,589 | 206,380 | 0.08% | Shares |
| Quadrature Capital Ltd | $437,825 | 210,493 | 0.08% | Shares |
| AMERICAN CENTURY COMPANIES INC | $431,400 | 207,404 | 0.08% | Shares |
| Headlands Technologies LLC | $427,342 | 205,453 | 0.08% | Shares |
| BARCLAYS PLC | $383,836 | 184,536 | 0.07% | Shares |
| OpenArc Corporate Advisory, LLC | $362,457 | 174,258 | 0.07% | Shares |
| CWM, LLC | $359,063 | 147,157 | 0.07% | Shares |
| Virtus Investment Advisers, LLC | $358,195 | 172,209 | 0.07% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $354,432 | 170,400 | 0.07% | Call option |
| PROFUND ADVISORS LLC | $352,972 | 169,698 | 0.07% | Shares |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | $336,122 | 161,597 | 0.06% | Shares |
| WINTON GROUP Ltd | $328,973 | 158,160 | 0.06% | Shares |
| MetLife Investment Management, LLC | $324,844 | 156,175 | 0.06% | Shares |
| Smartleaf Asset Management LLC | $306,080 | 137,874 | 0.06% | Shares |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $305,000 | 146,779 | 0.06% | Shares |
| JPMORGAN CHASE & CO | $291,295 | 131,214 | 0.05% | Shares |
| MARSHALL WACE, LLP | $290,479 | 139,653 | 0.05% | Shares |
| CHOREO, LLC | $260,129 | 125,062 | 0.05% | Shares |
| ALGERT GLOBAL LLC | $254,634 | 122,420 | 0.05% | Shares |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $254,234 | 122,228 | 0.05% | Shares |
| Quantbot Technologies LP | $243,221 | 116,933 | 0.05% | Shares |
| CANADA PENSION PLAN INVESTMENT BOARD | $240,240 | 115,500 | 0.05% | Shares |
| Graham Capital Management, L.P. | $237,992 | 114,419 | 0.04% | Shares |
| Invesco Ltd. | $215,130 | 103,428 | 0.04% | Shares |
| Engineers Gate Manager LP | $204,903 | 98,511 | 0.04% | Shares |
| BANK OF NOVA SCOTIA | $202,592 | 97,400 | 0.04% | Shares |
| Xcelsior Advisor Partners LLC | $199,661 | 95,991 | 0.04% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $194,773 | 93,641 | 0.04% | Shares |
| AXQ CAPITAL, LP | $173,091 | 83,217 | 0.03% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $171,392 | 82,400 | 0.03% | Put option |
| Mariner, LLC | $167,681 | 80,616 | 0.03% | Shares |
| CAPTRUST FINANCIAL ADVISORS | $164,730 | 79,197 | 0.03% | Shares |
| MORGAN STANLEY | $164,104 | 78,896 | 0.03% | Shares |
| Police & Firemen's Retirement System of New Jersey | $162,822 | 78,280 | 0.03% | Shares |
| D. E. Shaw & Co., Inc. | $157,196 | 75,575 | 0.03% | Shares |
| CITADEL ADVISORS LLC | $149,344 | 71,800 | 0.03% | Call option |
Company insiders 16 insiders · 6 officers · 8 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Zachary Roberts | President and CEO | July 1, 2026 A | — | 0 | 0 | $0 |
| David D Chang | President and CEO | March 23, 2022 A | 2,289,652 | 0 | 0 | $0 |
| Eric Thomas Schmidt | Chief Financial Officer | March 23, 2022 A | 337,904 | 0 | 0 | $0 |
| Rafael Amado | EVP of R&D and CMO | June 21, 2022 S | 544,257 | 0 | 0 | $0 |
| Veer Bhavnagri | General Counsel | March 23, 2022 A | 589,279 | 0 | 0 | $0 |
| Alison Moore | Chief Technical Officer | March 23, 2022 A | 120,430 | 0 | 0 | $0 |
| Stephen Mayo | Director | June 18, 2026 A | — | 0 | 0 | $0 |
| Elizabeth A. Barrett | Director | June 18, 2026 A | — | 0 | 0 | $0 |
| Deborah M. Messemer | Director | June 18, 2026 A | 6,535 | 0 | 0 | $0 |
| Owen N. Witte | Director | June 18, 2026 A | 233,271 | 0 | 0 | $0 |
| Franz B Humer | Director | June 18, 2026 A | 191,892 | 0 | 0 | $0 |
| Joshua A Kazam | Director | June 18, 2026 A | 398,463 | 0 | 0 | $0 |
| Vicki L Sato | Director | June 18, 2026 A | 41,451 | 0 | 0 | $0 |
| Pfizer Inc. | 10% owner | Oct. 15, 2018 C | 22,032,040 | 0 | 0 | $0 |
| Earl Martin Douglas | — | Feb. 2, 2026 A | 564,948 | 0 | 1 | $-40,304 |
| Arie Belldegrun | — | Feb. 2, 2026 A | 4,710,120 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 5 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Pfizer Inc. | Feb. 13, 2026 | 9.00% | Amendment | — | SEC |
| Pfizer Inc. (“Pfizer”) ×3 filings | Oct. 25, 2023 | — | Initial filing | — | SEC |
| TPG GP A, LLC, David Bonderman, James G. Coulter, Jon Winkelried | Jan. 18, 2022 | — | Initial filing | — | SEC |
| TPG Group Holdings (SBS) Advisors, Inc., David Bonderman, James G. Coulter ×4 filings | Aug. 10, 2020 | — | Initial filing | — | SEC |
| Pfizer Inc. (“ Pfizer ”) | Oct. 22, 2018 | — | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF ownership Held by 30 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 1.04% | 182,788 NS | April 30, 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.12% | 303,899 NS | April 30, 2026 | N-PORT |
| BIB · ProShares Trust | 0.02% | 8,308 NS | May 31, 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.02% | 204,346 NS | May 31, 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.01% | 876,401 NS | April 30, 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.01% | 1,207,257 NS | May 31, 2026 | N-PORT |
| ITWO · ProShares Trust | 0.01% | 7,333 NS | May 31, 2026 | N-PORT |
| UWM · ProShares Trust | 0.01% | 5,734 NS | May 31, 2026 | N-PORT |
| URTY · ProShares Trust | 0.00% | 5,798 NS | May 31, 2026 | N-PORT |
| HDG · ProShares Trust | 0.00% | 146 NS | May 31, 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.00% | 4,797 NS | May 31, 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 241,276 NS | April 30, 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 63,774 NS | April 30, 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 149,554 NS | May 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | July 15, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | — | — | July 15, 2026 | Daily |
| VFMO · VANGUARD WELLINGTON FUND | — | — | July 30, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | July 15, 2026 | Daily |
| VTWV · VANGUARD SCOTTSDALE FUNDS | — | — | July 15, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | July 15, 2026 | Daily |
| ITOT · iShares Trust | — | — | Aug. 4, 2026 | Daily |
| IWV · iShares Trust | — | — | Aug. 18, 2026 | Daily |
| IWN · iShares Trust | — | — | Aug. 17, 2026 | Daily |
| IWM · iShares Trust | — | — | Aug. 18, 2026 | Daily |
| IBB · iShares Trust | — | — | Aug. 18, 2026 | Daily |
| PRFZ · Invesco Exchange-Traded Fund Trust | — | — | July 13, 2026 | Daily |
| OMFS · Invesco Exchange-Traded Self-Indexe… | — | — | July 13, 2026 | Daily |
| VHT · VANGUARD WORLD FUND | — | — | July 20, 2026 | Daily |
| SMLF · iShares Trust | — | — | Aug. 10, 2026 | Daily |
| IBBQ · Invesco Exchange-Traded Fund Trust … | — | — | July 20, 2026 | Daily |